Effect of Dietary Protein on the Regulation of Exosome microRNA Expression in Patients With Insulin Resistance.

  • STATUS
    Recruiting
  • End date
    May 1, 2023
  • participants needed
    40
  • sponsor
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Updated on 26 April 2022

Summary

miRNAs are small non-coding RNAs of approximately 22 nucleotides in length, which have the function of regulating gene expression at the post-transcriptional level through base complementation of protein-coding transcripts, this interaction leading to translational repression by destabilizing the messenger RNA. Evidence demonstrates an association between differences in miRNA expression and the development of various pathologies, including obesity, type 2 diabetes, cardiovascular disease, neurodegenerative disorders and cancer. Other factors that could also modulate miRNA expression include nutritional status, diet and even exercise. The aim of this study is to identify exosome microRNAs that modify their expression in plasma from patients with insulin resistance fed different dietary protein sources. A randomized controlled clinical trial will be performed where the selected participants will be assigned by lottery to a dietary intervention of usual diet with protein of plant or animal origin for 4 weeks. The study will consist of 3 visits where anthropometric parameters, body composition, systolic and diastolic blood pressure, dietary compliance through 24-hour recall and food logs, biochemical tests (insulin, glucose, triglycerides, total cholesterol, HDL, LDL), the relative expression of plasma exosome miRNAs and markers of oxidative stress will be evaluated. Participants will receive a weekly food pantry during the first two visits in order to improve compliance to the dietary intervention.

Description

The study will evaluate the effect of 2 dietary interventions on the regulation of plasma exosome microRNA expression in patients with insulin resistance.

STUDY PROGRAM

The study will consist of 3 visits

Planned (selection of participants)

  1. Participants will be invited through advertisements.
  2. Participants will be corroborated to ensure that they meet the criteria for selection.
  3. If they are candidates for the protocol, participants will be provided with the letter of consent to read carefully and any doubts that may arise will be resolved. Participants will be informed about the characteristics of the study as well as the expected risks and benefits. If they agree, the participant will be asked to sign the consent form.
  4. Anthropometric measurements such as weight, height, blood pressure and body composition will be determined by means of bioelectrical impedance.
  5. A 24-hour reminder of food consumption will be made.
  6. A whole blood sample will be taken for glucose and insulin determination, in order to determine the HOMA-Insulin Resistance index.

Once the insulin resistance patients are identified (HOMA- Insulin Resistance ≥ 2.5) the study will begin and participants will be randomized into two intervention groups.

Visit 1 (baseline)

  1. A medical and nutritional assessment will be performed.
  2. The physical activity questionnaire (IPAQ long version) will be administered and participants will be advised not to change their physical activity.
  3. Anthropometric and blood pressure measurements will be taken.
  4. Oral glucose tolerance test will be performed for 2 hours after a 12-hour fast to determine the area under the insulin and glucose curve and determination of insulinemic and glycemic indices.
  5. A blood sample will be obtained to determine plasma exosome microRNA expression and C-reactive protein as a confounding variable for concurrent infection.
  6. The patient will be assigned to an intervention group (vegetable protein vs. animal protein) by block randomization.
  7. The participants will continue their usual diet, And the consumption of animal protein or the consumption of vegetable protein will be recommended, according to the assigned group. They will be given and explained a list of foods that provide proteins of animal and vegetable origin, which they could integrate into their usual diet, these lists will indicate which foods to consume and which not to consume, according to the intervention group to which they were assigned.
  8. They will be given a logbook to write down their daily food consumption and they will be taught how to fill it out.
  9. An online questionnaire will be explained how to fill out every third day to detect the consumption of recommended and non-recommended foods from the list provided, according to the assigned group.
  10. They will be given a pantry with foods rich in protein only (animal protein vs. vegetable protein) according to the assigned group (explained in the section on pantries).

Visit 2 (intermediate)

  1. Consumption logs will be collected.
  2. The weekly pantry will be delivered
  3. Clarification of doubts

Visit 3 (final)

  1. A medical and nutritional assessment will be performed. 2.
  2. The physical activity questionnaire (IPAQ long version) will be completed.
  3. Anthropometric and blood pressure measurements will be performed.
  4. Oral glucose tolerance test will be performed for 2 hours after a 12 hour fast to determine the area under the insulin and glucose curve and determination of insulinemic and glycemic indices.
  5. A blood sample will be obtained to determine plasma exosome microRNA expression and C-reactive protein as a confounding variable for concurrent infection.
  6. Body temperature will be determined and if female, the date of last menstrual period will be questioned as a confounding variable.
  7. The food log will be collected.
  8. Clarification of doubts and thanks will be given for their participation.

Details
Condition Insulin Resistance
Treatment Animal protein, Vegetal protein
Clinical Study IdentifierNCT05318898
SponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Last Modified on26 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Adults (men and women) between the ages of 18 and 60
Patients with obesity (BMI ≥ 30 and ≤ 50 kg / m2) and with insulin resistance (HOMA - Insulin Resistance Index ≥ 2.5)
Signature of letter of consent

Exclusion Criteria

Patients with any type of diabetes
Patients with kidney disease diagnosed by a medical or with creatinine> 1.3 mg / dL for men and > 1.1 mg / dL for women and / or blood urea nitrogen > 20 mg / dL
Patients with acquired diseases that produce obesity and diabetes secondarily
Patients who have suffered a cardiovascular event
Patients with weight loss > 3 kg in the last 3 months
Patients with any catabolic diseases
Gravidity status
Positive smoking and alcoholism
Treatment with any medication
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note